PROGNOSTIC ROLE OF CHRONIC HEART FAILURE SEVERITY MARKERS AND RISK STRATIFICATION IN PATIENTS AGED 75 YEARS OR OLDER: BNUP-AGE SURVIVAL MODEL (NEVA-75)
Abstract
To assess prognostic value of chronic heart failure (CHF) severity markers in patients aged over 74 years, and to optimise the risk stratification accordingly. This prospective study included 104 CHF patients aged 75 years or older, who were followed up for 2,5 years after hospital discharge. The effects of 150 clinical, instrumental, and laboratory parameters on survival were investigated. The survival over 2,5 years reached 30%. The main risk factors (RFs) of adverse outcome included age and levels of brain natriuretic peptide (BNUP). A prognostic model – BNUP-agE surVivAl model (NEVA-75) – was created. The main RFs of adverse outcome over 2,5 years of the follow-up were age and plasma BNUP levels. The model NEVA-75 could be used for assessing the prognosis and selecting the optimal therapeutic strategy in CHF patients aged over 74 years, who are discharged from hospital after CHF clinical stabilisation and are followed at a non-specialised polyclinic.
About the Authors
M. Yu. Sitnikova
Федеральное государственное учреждение “Федеральный центр сердца, крови и эндокринологии им. В.А. Алмазова” Росмедтехнологий, Санкт-Петербург
Russian Federation
Russian Federation
T. A. Lelyavina
Федеральное государственное учреждение “Федеральный центр сердца, крови и эндокринологии им. В.А. Алмазова” Росмедтехнологий, Санкт-Петербург
Russian Federation
Russian Federation
E. V. Shlyakhto
Федеральное государственное учреждение “Федеральный центр сердца, крови и эндокринологии им. В.А. Алмазова” Росмедтехнологий, Санкт-Петербург
Russian Federation
Russian Federation
V. V. Dorofeykov
Федеральное государственное учреждение “Федеральный центр сердца, крови и эндокринологии им. В.А. Алмазова” Росмедтехнологий, Санкт-Петербург
Russian Federation
Russian Federation
References
1. Remme W.J., McMurray J.J.V., Hobbs F.D.R. et al. Awareness and perception of heart failure among European cardiologists, internists, geriatricians and primary care physicians // Eur. Heart J. -2008. 10.1093/196.
2. Guidelines for diagnosis and treatment of Acute and Chronic heart failure // Eur. Heart J. 2008. - 10.1093/ 309.
3. Мареев В.Ю., Агеев Ф.Т., Арутюнов Г.П. и др. Национальные рекомендации по диагностике и лечению ХСН (второй пересмотр) // Сердечная Недостаточность. – 2007. – Т. 8. – №. 2. – С. 1-35.
4. Cody R.J. Clinical trials of diuretic therapy in heart failure: research direction and clinical considerations // J. Am. Coll. Cardiol. – 1993. – №. 22. – P. 165A-171A.
5. Gompertz, B. (1825). On the Nature of the Function Expressive of the Law of Human Mortality, and on a New Mode of Determining the Value of Life Contingencies //Philosophical Transactions of the Royal Society of London 115: 513–585.
6. Sitnikova М.Yu., Lelyavina Т.А., Slyakhto Е.W. еt al. Diagnosis and prognosis of hospitalized elderly heart failure patients // J. Heart Failure, Vol. 7, №. 2, 2006, P. 85-87.
7. Doust MH, Pietrzak E et al. How does BNP predict death and cardiac events in patients with heart failure: systematic review // BMJ. -2005 Mar. 19. – V. 330. – №. 7492. – P. 625.
8. Miller W.L., Bumen J.C., Hartman K.A. et al. Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict shot-term mortality in end stage heart failure patients treated with nesiritide. // Am J Cardiol. – 2005 Sep 15. – V. 96. – №. 6. – P. 837-841.
9. Ситникова М.Ю., Лелявина Т.А., Шляхто Е.В., Смирнов Б.И., Вологдина И.В. Особенности клиники, диагностики и прогноза хронической сердечной недостаточности у госпитализированных пациентов старческого возраста // Сердечная недостаточность. – 2006. – Том 7. – № 2. - С. 85-87.
10. Ситникова М.Ю., Лелявина Т.А., Шляхто Е.В. и др. Эффективность и прогностическая ценность методов диагностики тяжести хронической сердечной недостаточности у пациентов разного возраста // Артериальная гипертензия. – 2008. – Том. 14. – №. 1. – С. 5-11.
11. Valera-Roman A., Grigorian L., Barge E. et al. Heart failure in patients with preserved and deteriorated left ventricular ejection fraction // Heart. – 2005. – V. 91. – №. 4. – Р. 489-94.
12. Levy W.C., Mozzafarian D., Linker D.T. et al. The Siettle Heart Failure Model: prediction of survival in heart failure // Circulation. – 2006. – Vol. 113. – P. 1424-1433.
13. Shlyakhto E., Sitnikova M., Lelyavina T. The Age-BNP Survival Model: Prediction of survival in old (>75 years) patients with heart failure. // Circulation.-2008.- Vol.117. – № 19. – P. 486.
Review
For citations:
Sitnikova M.Yu., Lelyavina T.A., Shlyakhto E.V., Dorofeykov V.V. PROGNOSTIC ROLE OF CHRONIC HEART FAILURE SEVERITY MARKERS AND RISK STRATIFICATION IN PATIENTS AGED 75 YEARS OR OLDER: BNUP-AGE SURVIVAL MODEL (NEVA-75). Russian Journal of Cardiology. 2010;(5):23-29. (In Russ.)
Views:
644
Email this article 